nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—Rifampicin—leprosy	0.274	0.478	CbGbCtD
Posaconazole—CYP3A4—Rifampicin—leprosy	0.164	0.286	CbGbCtD
Posaconazole—CYP3A4—Dapsone—leprosy	0.136	0.236	CbGbCtD
Posaconazole—Hypoalbuminaemia—Dapsone—leprosy	0.0172	0.0404	CcSEcCtD
Posaconazole—Labyrinthine disorder—Thalidomide—leprosy	0.0153	0.036	CcSEcCtD
Posaconazole—Inner ear disorder—Thalidomide—leprosy	0.0153	0.036	CcSEcCtD
Posaconazole—Mental state abnormal—Thalidomide—leprosy	0.0142	0.0333	CcSEcCtD
Posaconazole—Acquired immunodeficiency syndrome—Thalidomide—leprosy	0.00957	0.0225	CcSEcCtD
Posaconazole—Myelodysplastic syndrome—Thalidomide—leprosy	0.00957	0.0225	CcSEcCtD
Posaconazole—Lipase increased—Thalidomide—leprosy	0.00653	0.0153	CcSEcCtD
Posaconazole—Autoimmune disorder—Thalidomide—leprosy	0.00575	0.0135	CcSEcCtD
Posaconazole—Albuminuria—Dapsone—leprosy	0.00502	0.0118	CcSEcCtD
Posaconazole—Meningitis—Thalidomide—leprosy	0.00495	0.0116	CcSEcCtD
Posaconazole—Rales—Thalidomide—leprosy	0.00468	0.011	CcSEcCtD
Posaconazole—Electrolyte imbalance—Thalidomide—leprosy	0.0046	0.0108	CcSEcCtD
Posaconazole—Ascites—Thalidomide—leprosy	0.00422	0.00993	CcSEcCtD
Posaconazole—Hyporeflexia—Thalidomide—leprosy	0.00422	0.00993	CcSEcCtD
Posaconazole—Raised liver function tests—Thalidomide—leprosy	0.00416	0.00977	CcSEcCtD
Posaconazole—Neck stiffness—Thalidomide—leprosy	0.00403	0.00947	CcSEcCtD
Posaconazole—Tongue discolouration—Thalidomide—leprosy	0.00397	0.00933	CcSEcCtD
Posaconazole—White blood cell count decreased—Thalidomide—leprosy	0.00386	0.00907	CcSEcCtD
Posaconazole—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00375	0.00881	CcSEcCtD
Posaconazole—Nuchal rigidity—Thalidomide—leprosy	0.0037	0.00869	CcSEcCtD
Posaconazole—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.0033	0.00776	CcSEcCtD
Posaconazole—Platelet count decreased—Thalidomide—leprosy	0.00323	0.00758	CcSEcCtD
Posaconazole—Febrile neutropenia—Thalidomide—leprosy	0.00319	0.0075	CcSEcCtD
Posaconazole—Deep vein thrombosis—Thalidomide—leprosy	0.00316	0.00741	CcSEcCtD
Posaconazole—Oral candidiasis—Thalidomide—leprosy	0.00302	0.0071	CcSEcCtD
Posaconazole—Hypomagnesaemia—Thalidomide—leprosy	0.00302	0.0071	CcSEcCtD
Posaconazole—Embolism—Thalidomide—leprosy	0.00299	0.00703	CcSEcCtD
Posaconazole—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00282	0.00662	CcSEcCtD
Posaconazole—Menstrual disorder—Thalidomide—leprosy	0.00282	0.00662	CcSEcCtD
Posaconazole—Hypercalcaemia—Thalidomide—leprosy	0.00276	0.00649	CcSEcCtD
Posaconazole—Hepatomegaly—Thalidomide—leprosy	0.00271	0.00637	CcSEcCtD
Posaconazole—Interstitial lung disease—Thalidomide—leprosy	0.00271	0.00637	CcSEcCtD
Posaconazole—Hyperlipidaemia—Thalidomide—leprosy	0.00266	0.00626	CcSEcCtD
Posaconazole—Psychotic disorder—Dapsone—leprosy	0.00266	0.00625	CcSEcCtD
Posaconazole—Neuritis—Thalidomide—leprosy	0.00257	0.00604	CcSEcCtD
Posaconazole—Albuminuria—Thalidomide—leprosy	0.00257	0.00604	CcSEcCtD
Posaconazole—Stupor—Thalidomide—leprosy	0.00257	0.00604	CcSEcCtD
Posaconazole—Cholestasis—Thalidomide—leprosy	0.00253	0.00594	CcSEcCtD
Posaconazole—Nasopharyngitis—Dapsone—leprosy	0.00243	0.00572	CcSEcCtD
Posaconazole—Muscular weakness—Dapsone—leprosy	0.0024	0.00564	CcSEcCtD
Posaconazole—Petechiae—Thalidomide—leprosy	0.00233	0.00548	CcSEcCtD
Posaconazole—Endocrine disorder—Thalidomide—leprosy	0.00232	0.00544	CcSEcCtD
Posaconazole—Pancreatitis—Dapsone—leprosy	0.00231	0.00542	CcSEcCtD
Posaconazole—Blood disorder—Thalidomide—leprosy	0.0023	0.0054	CcSEcCtD
Posaconazole—Musculoskeletal stiffness—Thalidomide—leprosy	0.00214	0.00503	CcSEcCtD
Posaconazole—Cellulitis—Thalidomide—leprosy	0.00211	0.00496	CcSEcCtD
Posaconazole—Hyperbilirubinaemia—Thalidomide—leprosy	0.00211	0.00496	CcSEcCtD
Posaconazole—Hypocalcaemia—Thalidomide—leprosy	0.0021	0.00493	CcSEcCtD
Posaconazole—Herpes simplex—Thalidomide—leprosy	0.00208	0.00489	CcSEcCtD
Posaconazole—Drug interaction—Thalidomide—leprosy	0.00207	0.00486	CcSEcCtD
Posaconazole—Hyperuricaemia—Thalidomide—leprosy	0.00207	0.00486	CcSEcCtD
Posaconazole—Neuropathy peripheral—Dapsone—leprosy	0.00206	0.00483	CcSEcCtD
Posaconazole—Hypercholesterolaemia—Thalidomide—leprosy	0.00203	0.00477	CcSEcCtD
Posaconazole—Hearing impaired—Thalidomide—leprosy	0.00202	0.00474	CcSEcCtD
Posaconazole—Bone pain—Thalidomide—leprosy	0.002	0.00471	CcSEcCtD
Posaconazole—Atrioventricular block—Thalidomide—leprosy	0.00198	0.00465	CcSEcCtD
Posaconazole—Sinusitis—Dapsone—leprosy	0.00197	0.00462	CcSEcCtD
Posaconazole—Gait disturbance—Thalidomide—leprosy	0.00197	0.00462	CcSEcCtD
Posaconazole—Blood uric acid increased—Thalidomide—leprosy	0.00195	0.00459	CcSEcCtD
Posaconazole—Phosphatase alkaline increased—Thalidomide—leprosy	0.00192	0.00451	CcSEcCtD
Posaconazole—Pulmonary embolism—Thalidomide—leprosy	0.00192	0.00451	CcSEcCtD
Posaconazole—Hepatocellular injury—Thalidomide—leprosy	0.00192	0.00451	CcSEcCtD
Posaconazole—Hyperkalaemia—Thalidomide—leprosy	0.00189	0.00443	CcSEcCtD
Posaconazole—Eructation—Thalidomide—leprosy	0.00189	0.00443	CcSEcCtD
Posaconazole—Pharyngitis—Dapsone—leprosy	0.00187	0.00439	CcSEcCtD
Posaconazole—Depressed level of consciousness—Thalidomide—leprosy	0.00185	0.00436	CcSEcCtD
Posaconazole—Candida infection—Thalidomide—leprosy	0.00183	0.00431	CcSEcCtD
Posaconazole—Blood urea increased—Thalidomide—leprosy	0.00181	0.00426	CcSEcCtD
Posaconazole—Neuropathy—Thalidomide—leprosy	0.0018	0.00423	CcSEcCtD
Posaconazole—Aplastic anaemia—Thalidomide—leprosy	0.0018	0.00423	CcSEcCtD
Posaconazole—Dry eye—Thalidomide—leprosy	0.00177	0.00417	CcSEcCtD
Posaconazole—Tinnitus—Dapsone—leprosy	0.00176	0.00413	CcSEcCtD
Posaconazole—Oesophagitis—Thalidomide—leprosy	0.00175	0.00412	CcSEcCtD
Posaconazole—Rash maculo-papular—Thalidomide—leprosy	0.00174	0.0041	CcSEcCtD
Posaconazole—Hyperkinesia—Thalidomide—leprosy	0.00167	0.00393	CcSEcCtD
Posaconazole—Mental disability—Thalidomide—leprosy	0.00167	0.00391	CcSEcCtD
Posaconazole—Sepsis—Thalidomide—leprosy	0.00167	0.00391	CcSEcCtD
Posaconazole—Erythema—Dapsone—leprosy	0.00164	0.00385	CcSEcCtD
Posaconazole—Lymphadenopathy—Thalidomide—leprosy	0.00163	0.00384	CcSEcCtD
Posaconazole—Thrombophlebitis—Thalidomide—leprosy	0.00161	0.00378	CcSEcCtD
Posaconazole—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.0016	0.00376	CcSEcCtD
Posaconazole—Gastroenteritis—Thalidomide—leprosy	0.00157	0.00369	CcSEcCtD
Posaconazole—Vascular purpura—Thalidomide—leprosy	0.00156	0.00366	CcSEcCtD
Posaconazole—Deafness—Thalidomide—leprosy	0.00156	0.00366	CcSEcCtD
Posaconazole—Vision blurred—Dapsone—leprosy	0.00154	0.00363	CcSEcCtD
Posaconazole—Eye pain—Thalidomide—leprosy	0.00154	0.00363	CcSEcCtD
Posaconazole—Injury—Thalidomide—leprosy	0.00152	0.00356	CcSEcCtD
Posaconazole—Renal failure acute—Thalidomide—leprosy	0.00151	0.00355	CcSEcCtD
Posaconazole—Libido decreased—Thalidomide—leprosy	0.0015	0.00353	CcSEcCtD
Posaconazole—Increased appetite—Thalidomide—leprosy	0.00148	0.00348	CcSEcCtD
Posaconazole—Amnesia—Thalidomide—leprosy	0.00148	0.00348	CcSEcCtD
Posaconazole—Vertigo—Dapsone—leprosy	0.00147	0.00346	CcSEcCtD
Posaconazole—Atrial fibrillation—Thalidomide—leprosy	0.00147	0.00346	CcSEcCtD
Posaconazole—Purpura—Thalidomide—leprosy	0.00145	0.0034	CcSEcCtD
Posaconazole—Cough—Dapsone—leprosy	0.00143	0.00336	CcSEcCtD
Posaconazole—Cardiac failure—Thalidomide—leprosy	0.00143	0.00336	CcSEcCtD
Posaconazole—Cerebrovascular accident—Thalidomide—leprosy	0.00142	0.00334	CcSEcCtD
Posaconazole—Hyponatraemia—Thalidomide—leprosy	0.0014	0.00329	CcSEcCtD
Posaconazole—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00139	0.00327	CcSEcCtD
Posaconazole—Pain in extremity—Thalidomide—leprosy	0.00139	0.00327	CcSEcCtD
Posaconazole—Diplopia—Thalidomide—leprosy	0.00139	0.00327	CcSEcCtD
Posaconazole—Disturbance in sexual arousal—Thalidomide—leprosy	0.00138	0.00325	CcSEcCtD
Posaconazole—Affect lability—Thalidomide—leprosy	0.00137	0.00322	CcSEcCtD
Posaconazole—Migraine—Thalidomide—leprosy	0.00137	0.00322	CcSEcCtD
Posaconazole—Psychotic disorder—Thalidomide—leprosy	0.00136	0.0032	CcSEcCtD
Posaconazole—Face oedema—Thalidomide—leprosy	0.00135	0.00316	CcSEcCtD
Posaconazole—Mood swings—Thalidomide—leprosy	0.00132	0.0031	CcSEcCtD
Posaconazole—Ataxia—Thalidomide—leprosy	0.00131	0.00308	CcSEcCtD
Posaconazole—Tachycardia—Dapsone—leprosy	0.00131	0.00307	CcSEcCtD
Posaconazole—Blood creatinine increased—Thalidomide—leprosy	0.00131	0.00307	CcSEcCtD
Posaconazole—Dehydration—Thalidomide—leprosy	0.0013	0.00304	CcSEcCtD
Posaconazole—Liver function test abnormal—Thalidomide—leprosy	0.00129	0.00302	CcSEcCtD
Posaconazole—Dry skin—Thalidomide—leprosy	0.00128	0.003	CcSEcCtD
Posaconazole—Orthostatic hypotension—Thalidomide—leprosy	0.00127	0.00299	CcSEcCtD
Posaconazole—Hypokalaemia—Thalidomide—leprosy	0.00127	0.00298	CcSEcCtD
Posaconazole—Breast disorder—Thalidomide—leprosy	0.00126	0.00296	CcSEcCtD
Posaconazole—Cramp muscle—Thalidomide—leprosy	0.00125	0.00295	CcSEcCtD
Posaconazole—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00125	0.00295	CcSEcCtD
Posaconazole—Muscular weakness—Thalidomide—leprosy	0.00123	0.00289	CcSEcCtD
Posaconazole—Alanine aminotransferase increased—Thalidomide—leprosy	0.00123	0.00289	CcSEcCtD
Posaconazole—Abdominal distension—Thalidomide—leprosy	0.00121	0.00285	CcSEcCtD
Posaconazole—Insomnia—Dapsone—leprosy	0.00121	0.00284	CcSEcCtD
Posaconazole—Dysphagia—Thalidomide—leprosy	0.0012	0.00283	CcSEcCtD
Posaconazole—Eosinophilia—Thalidomide—leprosy	0.00119	0.0028	CcSEcCtD
Posaconazole—Pancreatitis—Thalidomide—leprosy	0.00118	0.00277	CcSEcCtD
Posaconazole—Pancytopenia—Thalidomide—leprosy	0.00114	0.00269	CcSEcCtD
Posaconazole—Neutropenia—Thalidomide—leprosy	0.00113	0.00265	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Thalidomide—leprosy	0.00112	0.00263	CcSEcCtD
Posaconazole—Pollakiuria—Thalidomide—leprosy	0.00111	0.00261	CcSEcCtD
Posaconazole—Weight increased—Thalidomide—leprosy	0.0011	0.00258	CcSEcCtD
Posaconazole—Gastrointestinal pain—Dapsone—leprosy	0.00109	0.00257	CcSEcCtD
Posaconazole—Weight decreased—Thalidomide—leprosy	0.00109	0.00256	CcSEcCtD
Posaconazole—Hyperglycaemia—Thalidomide—leprosy	0.00109	0.00255	CcSEcCtD
Posaconazole—Pneumonia—Thalidomide—leprosy	0.00108	0.00254	CcSEcCtD
Posaconazole—Infestation NOS—Thalidomide—leprosy	0.00107	0.00252	CcSEcCtD
Posaconazole—Infestation—Thalidomide—leprosy	0.00107	0.00252	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00106	0.0025	CcSEcCtD
Posaconazole—Acute coronary syndrome—Thalidomide—leprosy	0.00106	0.00249	CcSEcCtD
Posaconazole—Abdominal pain—Dapsone—leprosy	0.00106	0.00249	CcSEcCtD
Posaconazole—Body temperature increased—Dapsone—leprosy	0.00106	0.00249	CcSEcCtD
Posaconazole—Renal failure—Thalidomide—leprosy	0.00106	0.00248	CcSEcCtD
Posaconazole—Neuropathy peripheral—Thalidomide—leprosy	0.00105	0.00247	CcSEcCtD
Posaconazole—Myocardial infarction—Thalidomide—leprosy	0.00105	0.00247	CcSEcCtD
Posaconazole—Stomatitis—Thalidomide—leprosy	0.00105	0.00246	CcSEcCtD
Posaconazole—Conjunctivitis—Thalidomide—leprosy	0.00104	0.00245	CcSEcCtD
Posaconazole—Haematuria—Thalidomide—leprosy	0.00102	0.00241	CcSEcCtD
Posaconazole—Epistaxis—Thalidomide—leprosy	0.00101	0.00238	CcSEcCtD
Posaconazole—Sinusitis—Thalidomide—leprosy	0.00101	0.00237	CcSEcCtD
Posaconazole—Agranulocytosis—Thalidomide—leprosy	0.001	0.00235	CcSEcCtD
Posaconazole—Bradycardia—Thalidomide—leprosy	0.000981	0.00231	CcSEcCtD
Posaconazole—Rhinitis—Thalidomide—leprosy	0.000966	0.00227	CcSEcCtD
Posaconazole—Hepatitis—Thalidomide—leprosy	0.000964	0.00227	CcSEcCtD
Posaconazole—Hypoaesthesia—Thalidomide—leprosy	0.000959	0.00225	CcSEcCtD
Posaconazole—Pharyngitis—Thalidomide—leprosy	0.000957	0.00225	CcSEcCtD
Posaconazole—Urinary tract disorder—Thalidomide—leprosy	0.000952	0.00224	CcSEcCtD
Posaconazole—Oedema peripheral—Thalidomide—leprosy	0.00095	0.00223	CcSEcCtD
Posaconazole—Urethral disorder—Thalidomide—leprosy	0.000945	0.00222	CcSEcCtD
Posaconazole—Erythema multiforme—Thalidomide—leprosy	0.000911	0.00214	CcSEcCtD
Posaconazole—Eye disorder—Thalidomide—leprosy	0.000901	0.00212	CcSEcCtD
Posaconazole—Tinnitus—Thalidomide—leprosy	0.000899	0.00211	CcSEcCtD
Posaconazole—Cardiac disorder—Thalidomide—leprosy	0.000895	0.0021	CcSEcCtD
Posaconazole—Angiopathy—Thalidomide—leprosy	0.000875	0.00206	CcSEcCtD
Posaconazole—Immune system disorder—Thalidomide—leprosy	0.000871	0.00205	CcSEcCtD
Posaconazole—Mediastinal disorder—Thalidomide—leprosy	0.000869	0.00204	CcSEcCtD
Posaconazole—Chills—Thalidomide—leprosy	0.000865	0.00203	CcSEcCtD
Posaconazole—Arrhythmia—Thalidomide—leprosy	0.000861	0.00202	CcSEcCtD
Posaconazole—Alopecia—Thalidomide—leprosy	0.000852	0.002	CcSEcCtD
Posaconazole—Vomiting—Dapsone—leprosy	0.000851	0.002	CcSEcCtD
Posaconazole—Mental disorder—Thalidomide—leprosy	0.000845	0.00198	CcSEcCtD
Posaconazole—Malnutrition—Thalidomide—leprosy	0.000839	0.00197	CcSEcCtD
Posaconazole—Headache—Dapsone—leprosy	0.000838	0.00197	CcSEcCtD
Posaconazole—Flatulence—Thalidomide—leprosy	0.000827	0.00194	CcSEcCtD
Posaconazole—Dysgeusia—Thalidomide—leprosy	0.000822	0.00193	CcSEcCtD
Posaconazole—Back pain—Thalidomide—leprosy	0.000812	0.00191	CcSEcCtD
Posaconazole—Muscle spasms—Thalidomide—leprosy	0.000807	0.0019	CcSEcCtD
Posaconazole—Nausea—Dapsone—leprosy	0.000795	0.00187	CcSEcCtD
Posaconazole—Vision blurred—Thalidomide—leprosy	0.000791	0.00186	CcSEcCtD
Posaconazole—Tremor—Thalidomide—leprosy	0.000786	0.00185	CcSEcCtD
Posaconazole—Ill-defined disorder—Thalidomide—leprosy	0.000779	0.00183	CcSEcCtD
Posaconazole—Anaemia—Thalidomide—leprosy	0.000776	0.00182	CcSEcCtD
Posaconazole—Agitation—Thalidomide—leprosy	0.000771	0.00181	CcSEcCtD
Posaconazole—Malaise—Thalidomide—leprosy	0.000757	0.00178	CcSEcCtD
Posaconazole—Vertigo—Thalidomide—leprosy	0.000754	0.00177	CcSEcCtD
Posaconazole—Syncope—Thalidomide—leprosy	0.000753	0.00177	CcSEcCtD
Posaconazole—Leukopenia—Thalidomide—leprosy	0.000751	0.00177	CcSEcCtD
Posaconazole—Loss of consciousness—Thalidomide—leprosy	0.000738	0.00173	CcSEcCtD
Posaconazole—Cough—Thalidomide—leprosy	0.000732	0.00172	CcSEcCtD
Posaconazole—Convulsion—Thalidomide—leprosy	0.000727	0.00171	CcSEcCtD
Posaconazole—Hypertension—Thalidomide—leprosy	0.000725	0.0017	CcSEcCtD
Posaconazole—Arthralgia—Thalidomide—leprosy	0.000714	0.00168	CcSEcCtD
Posaconazole—Chest pain—Thalidomide—leprosy	0.000714	0.00168	CcSEcCtD
Posaconazole—Myalgia—Thalidomide—leprosy	0.000714	0.00168	CcSEcCtD
Posaconazole—Anxiety—Thalidomide—leprosy	0.000712	0.00167	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00071	0.00167	CcSEcCtD
Posaconazole—Discomfort—Thalidomide—leprosy	0.000706	0.00166	CcSEcCtD
Posaconazole—Dry mouth—Thalidomide—leprosy	0.000699	0.00164	CcSEcCtD
Posaconazole—Confusional state—Thalidomide—leprosy	0.000691	0.00162	CcSEcCtD
Posaconazole—Oedema—Thalidomide—leprosy	0.000685	0.00161	CcSEcCtD
Posaconazole—Infection—Thalidomide—leprosy	0.00068	0.0016	CcSEcCtD
Posaconazole—Shock—Thalidomide—leprosy	0.000674	0.00158	CcSEcCtD
Posaconazole—Nervous system disorder—Thalidomide—leprosy	0.000672	0.00158	CcSEcCtD
Posaconazole—Thrombocytopenia—Thalidomide—leprosy	0.000671	0.00158	CcSEcCtD
Posaconazole—Tachycardia—Thalidomide—leprosy	0.000668	0.00157	CcSEcCtD
Posaconazole—Skin disorder—Thalidomide—leprosy	0.000665	0.00156	CcSEcCtD
Posaconazole—Hyperhidrosis—Thalidomide—leprosy	0.000662	0.00156	CcSEcCtD
Posaconazole—Anorexia—Thalidomide—leprosy	0.000653	0.00153	CcSEcCtD
Posaconazole—Hypotension—Thalidomide—leprosy	0.00064	0.0015	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Thalidomide—leprosy	0.000624	0.00147	CcSEcCtD
Posaconazole—Insomnia—Thalidomide—leprosy	0.000619	0.00146	CcSEcCtD
Posaconazole—Paraesthesia—Thalidomide—leprosy	0.000615	0.00145	CcSEcCtD
Posaconazole—Dyspnoea—Thalidomide—leprosy	0.000611	0.00143	CcSEcCtD
Posaconazole—Somnolence—Thalidomide—leprosy	0.000609	0.00143	CcSEcCtD
Posaconazole—Dyspepsia—Thalidomide—leprosy	0.000603	0.00142	CcSEcCtD
Posaconazole—Decreased appetite—Thalidomide—leprosy	0.000595	0.0014	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Thalidomide—leprosy	0.000591	0.00139	CcSEcCtD
Posaconazole—Fatigue—Thalidomide—leprosy	0.00059	0.00139	CcSEcCtD
Posaconazole—Pain—Thalidomide—leprosy	0.000586	0.00138	CcSEcCtD
Posaconazole—Constipation—Thalidomide—leprosy	0.000586	0.00138	CcSEcCtD
Posaconazole—Feeling abnormal—Thalidomide—leprosy	0.000564	0.00133	CcSEcCtD
Posaconazole—Gastrointestinal pain—Thalidomide—leprosy	0.00056	0.00132	CcSEcCtD
Posaconazole—Urticaria—Thalidomide—leprosy	0.000544	0.00128	CcSEcCtD
Posaconazole—Abdominal pain—Thalidomide—leprosy	0.000541	0.00127	CcSEcCtD
Posaconazole—Body temperature increased—Thalidomide—leprosy	0.000541	0.00127	CcSEcCtD
Posaconazole—Hypersensitivity—Thalidomide—leprosy	0.000505	0.00119	CcSEcCtD
Posaconazole—Asthenia—Thalidomide—leprosy	0.000491	0.00115	CcSEcCtD
Posaconazole—Pruritus—Thalidomide—leprosy	0.000485	0.00114	CcSEcCtD
Posaconazole—Diarrhoea—Thalidomide—leprosy	0.000469	0.0011	CcSEcCtD
Posaconazole—Dizziness—Thalidomide—leprosy	0.000453	0.00106	CcSEcCtD
Posaconazole—Vomiting—Thalidomide—leprosy	0.000435	0.00102	CcSEcCtD
Posaconazole—Rash—Thalidomide—leprosy	0.000432	0.00101	CcSEcCtD
Posaconazole—Dermatitis—Thalidomide—leprosy	0.000431	0.00101	CcSEcCtD
Posaconazole—Headache—Thalidomide—leprosy	0.000429	0.00101	CcSEcCtD
Posaconazole—Nausea—Thalidomide—leprosy	0.000407	0.000956	CcSEcCtD
